BREAKING: A federal judge ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry. https://t.co/FFgjl8G0hR
— The Associated Press (@AP) January 14, 2022